Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 206

Related Articles by Review for PubMed (Select 16437456)

1.

Antidepressants for depressed elderly.

Mottram P, Wilson K, Strobl J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003491. Review.

PMID:
16437456
2.

Antidepressants versus placebo for depression in primary care.

Arroll B, Elley CR, Fishman T, Goodyear-Smith FA, Kenealy T, Blashki G, Kerse N, Macgillivray S.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007954. doi: 10.1002/14651858.CD007954. Review.

PMID:
19588448
3.

Fluoxetine versus other types of pharmacotherapy for depression.

Magni LR, Purgato M, Gastaldon C, Papola D, Furukawa TA, Cipriani A, Barbui C.

Cochrane Database Syst Rev. 2013 Jul 17;7:CD004185. Review.

PMID:
24353997
4.

Pharmacological interventions for somatoform disorders in adults.

Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ.

Cochrane Database Syst Rev. 2014 Nov 7;11:CD010628. doi: 10.1002/14651858.CD010628.pub2. Review.

PMID:
25379990
5.

Agomelatine versus other antidepressive agents for major depression.

Guaiana G, Gupta S, Chiodo D, Davies SJ, Haederle K, Koesters M.

Cochrane Database Syst Rev. 2013 Dec 17;12:CD008851. doi: 10.1002/14651858.CD008851.pub2. Review.

PMID:
24343836
6.

WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).

Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, Hardy R, Lewis G, Mason JM.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD002791. Review.

PMID:
17636706
7.

Fluoxetine versus other types of pharmacotherapy for depression.

Cipriani A, Brambilla P, Furukawa T, Geddes J, Gregis M, Hotopf M, Malvini L, Barbui C.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004185. Review. Update in: Cochrane Database Syst Rev. 2013;7:CD004185.

8.

Antidepressant versus placebo for depressed elderly.

Wilson K, Mottram P, Sivanranthan A, Nightingale A.

Cochrane Database Syst Rev. 2001;(2):CD000561. Review.

PMID:
11405969
9.

Newer generation antidepressants for depressive disorders in children and adolescents.

Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD004851. doi: 10.1002/14651858.CD004851.pub3. Review.

PMID:
23152227
10.

Antidepressants for people with epilepsy and depression.

Maguire MJ, Weston J, Singh J, Marson AG.

Cochrane Database Syst Rev. 2014 Dec 3;12:CD010682. doi: 10.1002/14651858.CD010682.pub2. Review.

PMID:
25464360
11.

Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.

Mead GE, Hsieh CF, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, Hackett ML.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD009286. doi: 10.1002/14651858.CD009286.pub2. Review.

PMID:
23152272
12.

Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.

Barbui C, Hotopf M, Freemantle N, Boynton J, Churchill R, Eccles MP, Geddes JR, Hardy R, Lewis G, Mason JM.

Cochrane Database Syst Rev. 2000;(4):CD002791. Review. Update in: Cochrane Database Syst Rev. 2006;(3):CD002791.

PMID:
11034764
13.

Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.

Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; MANGA (Meta-Analysis of New Generation Antidepressants) Study Group.

CNS Drugs. 2010 Jan;24(1):35-53. doi: 10.2165/11319480-000000000-00000. Review.

PMID:
20030418
14.

Amitriptyline for depression.

Guaiana G, Barbui C, Hotopf M.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004186. Review.

PMID:
17636748
15.

Tricyclic drugs for depression in children and adolescents.

Hazell P, Mirzaie M.

Cochrane Database Syst Rev. 2013 Jun 18;6:CD002317. doi: 10.1002/14651858.CD002317.pub2. Review.

PMID:
23780719
16.

Antidepressants for agitation and psychosis in dementia.

Seitz DP, Adunuri N, Gill SS, Gruneir A, Herrmann N, Rochon P.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD008191. doi: 10.1002/14651858.CD008191.pub2. Review.

PMID:
21328305
17.

Fluvoxamine versus other anti-depressive agents for depression.

Omori IM, Watanabe N, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006114. doi: 10.1002/14651858.CD006114.pub2. Review.

18.

Sertraline versus other antidepressive agents for depression.

Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD006117. doi: http://dx.doi.org/10.1002/14651858.CD006117. Review. Update in: Cochrane Database Syst Rev. 2010;(4):CD006117.

PMID:
20091586
19.

Sertraline versus other antidepressive agents for depression.

Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006117. doi: 10.1002/14651858.CD006117.pub2. Review. Update in: Cochrane Database Syst Rev. 2010;(1):CD006117.

PMID:
19370626
20.

Milnacipran versus other antidepressive agents for depression.

Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006529. doi: 10.1002/14651858.CD006529.pub2. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk